淮安大型工业吸尘器茂名大功率工业吸尘器,四平大功率工业吸尘器,泉州工业吸尘器,商丘工业吸尘器,黄山大功率工业吸尘器,湖州大功率工业吸尘器,东营大型工业吸尘器

After Denmark's Prime Minister Mette Frederiksen said that Greenland is not for sale, President Donald Trump said on Tuesday evening that he will postpone an upcoming meeting between the two leaders, citing Frederiksen's comments as the reason. Trump said on Sunday that his meeting with Frederiksen was "not for this reason at all. But we're looking at it."But Trump's tweet goes against what he said on Sunday. "Denmark is a very special country with incredible people, but based on Prime Minister Mette Frederiksen’s comments, that she would have no interest in discussing the purchase of Greenland," Trump tweeted, "I will be postponing our meeting scheduled in two weeks for another time. The Prime Minister was able to save a great deal of expense and effort for both the United States and Denmark by being so direct. I thank her for that and look forward to rescheduling sometime in the future!"Trump's interest in Greenland was revealed last week. The island, which is the world's largest by land area, has 55,000 residents. While Greenland is an autonomous nation for domestic issues, Denmark manages the island's foreign policy.Frederiksen 1162

Activists with the environmental organization Greenpeace are currently hanging from a bridge from Houston in an attempt to block a shipping channel known for transporting oil.According to KHOU-TV, a portion of the Houston Ship Channel was blocked on Thursday as activists hung from the Fred Hartman Bridge. KHOU reports that 11 people were hanging from the bridge.Greenpeace took credit for the incident in a series of tweets, using the hashtag #PeopleVsOil.Greenpeace says it plans to continue the protest for 24 hours.Car traffic on the bridge is slow but moving.Greenpeace's demonstration comes on the same day as a Democrat debate that will take place in Houston this evening. 692

A University of Utah senior missing for more than a week was last seen at a park where she met someone in a car, Salt Lake City police said.Mackenzie Lueck, 23, arrived at Salt Lake City International Airport on June 17 after visiting family.She then took a Lyft to Hatch Park in North Salt Lake, where she was last seen in the early-morning hours."Mackenzie was met at Hatch Park by an individual in a vehicle. The Lyft driver left Mackenzie at the park with that person and stated that Mackenzie did not appear to be in any type of distress," Assistant Police Chief Tim Doubt told reporters on Monday.Doubt said detectives are canvassing the area around the park and are looking for video surveillance. He said police have not yet confirmed the make or model of the car or obtained a description of the person."To date the family and her friends have not heard from her," Doubt said. Police confirmed she missed a flight to Los Angeles on the morning of June 23. He said Lueck, who lives in an apartment in Salt Lake City, also missed a midterm exam."At this time there is no evidence that any harm has come to her. However because of the circumstances of the case we want to make sure that she is all right."Police said Lyft and the Lyft driver have cooperated with the investigation. The Lyft driver confirmed the route Lueck took and said she met someone after she was dropped off.Lyft said that the route had no irregularities and ended at the destination Lueck entered. The driver continued providing rides immediately after the ride ended, the company said."We recognize how scary this must be for those who know and love Ms. Lueck," Lyft said. "The safety of our community is fundamental to Lyft and we are actively assisting law enforcement with their investigation."Authorities believe her phone has not been on since June 17. They haven't been able to find its location, police said.Police said that sometimes missing people don't want to be reached. If that is the case, they ask Lueck to reach out to police to let them know if she is safe."Mackenzie, we are asking you to please reach out to either the Salt Lake City police department or a law enforcement agency where you are at. We want to make sure you are safe and we will respect your wishes," Doubt said.Police have set up a tip line -- 801-799-4420."We are asking anyone with information to please contact us," Doubt said.Friend and sorority sister Ashley Fine told 2452

A pinch in the leg, a squeal and a trickle of tears. One baby after another in Malawi is getting the first and only vaccine against malaria, one of history’s deadliest and most stubborn of diseases.The southern African nation is rolling out the shots in an unusual pilot program along with Kenya and Ghana. Unlike established vaccines that offer near-complete protection, this new one is only about 40% effective. But experts say it’s worth a try as progress against malaria stalls: Resistance to treatment is growing and the global drop in cases has leveled off. With the vaccine, the hope is to help small children through the most dangerous period of their lives. Spread by mosquito bites, malaria kills more than 400,000 people every year, two-thirds of them under 5 and most in Africa.Seven-month-old Charity Nangware received a shot on a rainy December day at a health clinic in the town of Migowi. She watched curiously as the needle slid into her thigh, then twisted up her face with a howl.“I’m very excited about this,” said her mother, Esther Gonjani, who herself gets malaria’s aches, chills and fever at least once a year and loses a week of field work when one of her children is ill. “They explained it wasn’t perfect, but I feel secure it will relieve the pain.”There is little escaping malaria -- “malungo” in the local Chichewa language -- especially during the five-month rainy season. Stagnant puddles, where mosquitoes breed, surround the homes of brick and thatch and line the dirt roads through tea plantations or fields of maize and sugar cane. In the village of Tomali, the nearest health clinic is a two-hour bike ride away. The longer it takes to get care, the more dangerous malaria can be. Teams from the clinic offer basic medical care during visits once or twice a month, bringing the malaria shot and other vaccines in portable coolers. Treating malaria takes up a good portion of their time during the rainy season, according to Daisy Chikonde, a local health worker.“If this vaccine works, it will reduce the burden,” she said.Resident Doriga Ephrem proudly said her 5-month-old daughter, Grace, didn’t cry when she got the malaria shot.When she heard about the vaccine, Ephrem said her first thought was “protection is here.” Health workers explained, however, that the vaccine is not meant to replace antimalarial drugs or the insecticide-treated bed net she unfolds every night as the sun sets and mosquitoes rise from the shadows. “We even take our evening meals inside the net to avoid mosquitoes,” she said.It took three decades of research to develop the new vaccine, which works against the most common and deadly of the five parasite species that cause malaria. The parasite’s complex life cycle is a huge challenge. It changes forms in different stages of infection and is far harder to target than germs.“We don’t have any vaccines against parasites in routine use. This is uncharted territory,” said Ashley Birkett, who directs PATH’s Malaria Vaccine Initiative, a nonprofit that helped drugmaker GlaxoSmithKline develop the shot, brand-named Mosquirix. The bite of an infected mosquito sends immature parasites called sporozoites into the bloodstream. If they reach the liver, they’ll mature and multiply before spewing back into the blood to cause malaria’s debilitating symptoms. At that point, treatment requires medicines that kill the parasites.Mosquirix uses a piece of the parasite — a protein found only on sporozoites’ surface — in hopes of blocking the liver stage of infection. When a vaccinated child is bitten, the immune system should recognize the parasite and start making antibodies against it.Scientists also are searching for next-generation alternatives. In the pipeline is an experimental vaccine made of whole malaria parasites dissected from mosquitoes’ salivary glands but weakened so they won’t make people sick. Sanaria Inc. has been testing its vaccine in adults, and is planning a large, late-stage study in Equatorial Guinea’s Bioko Island.And the U.S. National Institutes of Health soon will start initial tests of whether injecting people periodically with lab-made antibodies, rather than depending on the immune system to make them, could offer temporary protection during malaria season. Think of them as “potentially short-term vaccines,” NIH’s Dr. Robert Seder told a recent meeting of the American Society of Tropical Medicine and Hygiene.For now, only babies in parts of Malawi, Kenya and Ghana are eligible for the Mosquirix vaccine. After the vaccine was approved in 2015, the World Health Organization said it first wanted a pilot roll-out to see how well it worked in a few countries — in real-world conditions — before recommending that the vaccine be given more widely across Africa. “Everyone is looking forward to getting it,” said Temwa Mzengeza, who oversees Malawi’s vaccine programs. Those eager for the shots include her husband, whom she had to stop from trying to get them, she said.Mzengeza used to come down with malaria several times a year until she started following her own advice to sleep under a net every night. Unlike many other kinds of infections, people can get malaria repeatedly, building up only a partial immunity.In the pilot program that began last year, 360,000 children in the three countries are meant to be vaccinated annually. The first dose is given at about age 5 months and the final, fourth booster near the child’s second birthday.Experts say it is too early to know how well the vaccine is working. They’re watching for malaria deaths, severe infections and cases of meningitis, something reported during studies but not definitively linked to the vaccine.“To do something completely new for malaria is exciting,” said researcher Don Mathanga, who is leading the evaluation in Malawi. The rainy season has brought new challenges, making some rural roads impassable and complicating efforts to track down children due for a shot. So far in Malawi, the first dose reached about half of the children targeted, about 35,000. That dropped to 26,000 for the second dose and 20,000 for the third. That’s not surprising for a new vaccine, Mzengeza said. “It will pick up with time.”At the health clinic in Migowi in Malawi’s southern highlands, workers see signs of hope. Henry Kadzuwa explains the vaccine to mothers waiting at the clinic. He said there was a drop in malaria cases to 40 in the first five months of the program, compared to 78 in the same period in 2018.Even though he wishes his 3-year-old daughter, Angel, could receive the vaccine, “it’s protecting my community. It also makes my work easier,” Kadzuwa said. The Migowi area has one of the country’s highest rates of malaria, and a worn paper register in the clinic’s laboratory lists scores of cases.At the clinic, Agnes Ngubale said she had malaria several years ago and wants to protect her 6-month-old daughter, Lydia, from the disease.“I want her to be healthy and free,” she said. “I want her to be a doctor.”And she has memorized the time for Lydia’s second dose: “Next month, same date.”___Neergaard reported from Washington.___The Associated Press Health and Science Department receives 7200

All of us here at @PeteForAmerica are sending our best wishes for a speedy recovery to Senator @BernieSanders. We're thinking of him and his family today, and I look forward to seeing him back on the campaign trail very soon.— Pete Buttigieg (@PeteButtigieg) October 2, 2019 286